Proceedings from the CIH(LMU) 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”

The 5th CIH(LMU) Infectious Disease Symposium, Munich, Germany, March 12, 2016 brought together Tuberculosis Experts from developed and low middle-income countries to discuss the control of drug resistance Tuberculosis. The meeting featured 9 presentations: Tuberculosis history and current scenario,...

Descripción completa

Detalles Bibliográficos
Autores principales: Khosa, Celso, Patel, Krutarth, Abdiyeva, Karlygash, Turebekov, Nurkeldi, Prüller, Bettina, Heinrich, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Proceedings
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592439/
https://www.ncbi.nlm.nih.gov/pubmed/28904562
http://dx.doi.org/10.1186/s12919-017-0077-6
_version_ 1783262880104185856
author Khosa, Celso
Patel, Krutarth
Abdiyeva, Karlygash
Turebekov, Nurkeldi
Prüller, Bettina
Heinrich, Norbert
author_facet Khosa, Celso
Patel, Krutarth
Abdiyeva, Karlygash
Turebekov, Nurkeldi
Prüller, Bettina
Heinrich, Norbert
author_sort Khosa, Celso
collection PubMed
description The 5th CIH(LMU) Infectious Disease Symposium, Munich, Germany, March 12, 2016 brought together Tuberculosis Experts from developed and low middle-income countries to discuss the control of drug resistance Tuberculosis. The meeting featured 9 presentations: Tuberculosis history and current scenario, Tuberculosis and migration - current scenario in Germany, Mechanism of Tuberculosis resistance development, Epidemiology of resistance – transmission vs. new generation of resistance, The impact of diagnostic in patients beyond – sensitivity and specificity, The Bangladesh regimen – new hope trough old drugs, New drugs and regimens – an overview on studies and Multi and Extensively Drug Resistant Tuberculosis from Europe. The presentations were followed by a panel discussion. Serious Multidrug Resistance epidemic in some countries may jeopardize the progress in Tuberculosis control. In this meeting epidemiology, mechanism, immigration and screening, diagnosis, research and treatment of drug resistant tuberculosis were discussed.
format Online
Article
Text
id pubmed-5592439
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55924392017-09-13 Proceedings from the CIH(LMU) 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge” Khosa, Celso Patel, Krutarth Abdiyeva, Karlygash Turebekov, Nurkeldi Prüller, Bettina Heinrich, Norbert BMC Proc Proceedings The 5th CIH(LMU) Infectious Disease Symposium, Munich, Germany, March 12, 2016 brought together Tuberculosis Experts from developed and low middle-income countries to discuss the control of drug resistance Tuberculosis. The meeting featured 9 presentations: Tuberculosis history and current scenario, Tuberculosis and migration - current scenario in Germany, Mechanism of Tuberculosis resistance development, Epidemiology of resistance – transmission vs. new generation of resistance, The impact of diagnostic in patients beyond – sensitivity and specificity, The Bangladesh regimen – new hope trough old drugs, New drugs and regimens – an overview on studies and Multi and Extensively Drug Resistant Tuberculosis from Europe. The presentations were followed by a panel discussion. Serious Multidrug Resistance epidemic in some countries may jeopardize the progress in Tuberculosis control. In this meeting epidemiology, mechanism, immigration and screening, diagnosis, research and treatment of drug resistant tuberculosis were discussed. BioMed Central 2017-09-04 /pmc/articles/PMC5592439/ /pubmed/28904562 http://dx.doi.org/10.1186/s12919-017-0077-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Proceedings
Khosa, Celso
Patel, Krutarth
Abdiyeva, Karlygash
Turebekov, Nurkeldi
Prüller, Bettina
Heinrich, Norbert
Proceedings from the CIH(LMU) 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”
title Proceedings from the CIH(LMU) 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”
title_full Proceedings from the CIH(LMU) 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”
title_fullStr Proceedings from the CIH(LMU) 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”
title_full_unstemmed Proceedings from the CIH(LMU) 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”
title_short Proceedings from the CIH(LMU) 5th Infectious Diseases Symposium 2016 “Drug Resistant Tuberculosis: Old Disease - New Challenge”
title_sort proceedings from the cih(lmu) 5th infectious diseases symposium 2016 “drug resistant tuberculosis: old disease - new challenge”
topic Proceedings
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592439/
https://www.ncbi.nlm.nih.gov/pubmed/28904562
http://dx.doi.org/10.1186/s12919-017-0077-6
work_keys_str_mv AT khosacelso proceedingsfromthecihlmu5thinfectiousdiseasessymposium2016drugresistanttuberculosisolddiseasenewchallenge
AT patelkrutarth proceedingsfromthecihlmu5thinfectiousdiseasessymposium2016drugresistanttuberculosisolddiseasenewchallenge
AT abdiyevakarlygash proceedingsfromthecihlmu5thinfectiousdiseasessymposium2016drugresistanttuberculosisolddiseasenewchallenge
AT turebekovnurkeldi proceedingsfromthecihlmu5thinfectiousdiseasessymposium2016drugresistanttuberculosisolddiseasenewchallenge
AT prullerbettina proceedingsfromthecihlmu5thinfectiousdiseasessymposium2016drugresistanttuberculosisolddiseasenewchallenge
AT heinrichnorbert proceedingsfromthecihlmu5thinfectiousdiseasessymposium2016drugresistanttuberculosisolddiseasenewchallenge

Ejemplares similares